stockrow
Friday 6 November 2026
Export IRMD’s income statement to Excel — free account
iRadimed Corporation
IRMD Healthcare Medical Devices
iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024.
- Revenue
- +14.2%
- EPS
- +15.9%
- Free cash flow
- +18.6%
Quarter to September 2026, against a year earlier
84.44
1.10
−1.29%
Follow IRMD
Alert me
iRadimed Corporation (IRMD) P/E ratio
As of 5 November 2026, iRadimed Corporation (IRMD) trades at a P/E ratio of 44.9×. Over the past ten years it has ranged from 11.5× (November 2016) to 372× (June 2021); the current reading is higher than 56% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 55.0× | 52.89% |
| FY2024 | 35.9× | 3.38% |
| FY2023 | 34.8× | 24.53% |
| FY2022 | 27.9× | (54.68%) |
| FY2021 | 61.6× | (67.57%) |
| FY2020 | 190× | 598.89% |
| FY2019 | 27.2× | (34.42%) |
| FY2018 | 41.5× | (86.45%) |
| FY2017 | 306× | 1,757.86% |
| FY2016 | 16.5× | (59.46%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 45.6× | (13.12%) |
| Jun 2026 | 52.5× | 1.45% |
| Mar 2026 | 51.8× | (5.84%) |
| Dec 2025 | 55.0× | 28.98% |
| 43 more quarters | Free account |
Against its own ten years
Low 11.5×
High 372×
Ten-year median
40.5×
Current reading's percentile
61
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AORT Artivion, Inc. compare | n/m |
| CBLL CeriBell, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| LMRI Lumexa Imaging Holdings, Inc. compare | n/m |
| SIBN SiBone compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| PRCT PROCEPT BioRobotics Corporation compare | n/m |
| IRMD iRadimed Corporation | 44.9× |
| IART Integra LifeSciences Holdings Corporation compare | 83.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)